Maternal circulating status of vitamin D, adiponectin and lipid ratios in gestational diabetes mellitus by Khosrowbeygi, Ali & Ahmadvand, Hassan
Address for correspondence:  
Ali Khosrowbeygi 
Department of Biochemistry and Genetics
School of Medicine, Arak University 
of Medical Sciences, Arak, Iran
Phone: +98 86 34173528
Fax: +98 86 34173529
e-mail: khosrowbeygi@yahoo.com, 
a.khosrowbeygi@arakmu.ac.ir
Clinical Diabetology 2020, 9; 5: 321–327
DOI: 10.5603/DK.2020.0038
Received: 15.06.2020  Accepted: 03.08.2020
 ORIGINAL ARTICLE ISSN 2450–7458
321
Ali Khosrowbeygi1 , Hassan Ahmadvand2
1School of Medicine, Arak University of Medical Sciences, Arak, Iran 
2School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
Maternal circulating status of vitamin D, 
adiponectin and lipid ratios in gestational 
diabetes mellitus
ABSTRACT 
Background. The present research was an attempt to 
assess maternal serum values of 25-hydroxy vitamin 
D3 [25(OH)D3], adiponectin and the lipid ratios and 
comparison of their associations with insulin resista-
nce and insulin sensitivity in gestational diabetes 
mellitus (GDM). 
Material and methods. It was conducted on 100 par-
ticipants including 49 women with GDM and 51 normal 
pregnant women at 24–28 weeks of gestation. Mater-
nal fasting serum values of glucose, 25(OH)D3, lipid 
profile, adiponectin and insulin were assessed and the 
lipid ratios and biomarkers of resistance and sensitivity 
to insulin were calculated. Statistical significance was 
set at P < 0.05. 
Results. Current research revealed that levels of 25(OH)
D3 were significantly lower in GDM than in normal 
pregnancy. Binary logistic regression analysis showed 
that GDM was associated negatively with 25(OH)D3, 
HDL-C and adiponectin and positively with the lipid 
ratios. Multiple linear regression analysis showed that 
only values of 25(OH)D3 were independently associated 
negatively with the insulin resistance (P = 0.012). 
Conclusions. Levels of 25(OH)D3 were significantly 
decreased in GDM compared with normal pregnancy. 
On the other hand, 25(OH)D3 had a significant negative 
correlation with insulin resistance which was stronger 
than the lipid ratios and adiponectin. (Clin Diabet 2020; 
9; 5: 321–327)
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Introduction
Gestational diabetes mellitus (GDM) is a kind of 
diabetes that is characterized with hyperglycemia 
during pregnancy with a prevalence of approximately 
15–20 percent of all pregnancies in the world. After 
pregnancy, the prevalence of type 2 diabetes mellitus 
and cardiovascular diseases are high in women with 
GDM and also in their offspring [1, 2]. 
Vitamin D deficiency might lead to some important 
problems in pregnancy. Vitamin D has some regulatory 
functions on many of cells in addition to its tradition-
ally been known role in calcium metabolism and bone 
turnover [3, 4]. Indirect relationship between vitamin 
D insufficiency and increased risk of clinically complica-
tions such as diabetes, metabolic syndrome, obesity, 
hypertension and cardiovascular diseases have been 
reported [2, 3, 5]. 
The findings of association of serum levels of vi-
tamin D with insulin resistance and insulin sensitivity 
parameters in GDM are conflicting [6–9]. On the other 
hand, few reports are available about the relationship 
between levels of vitamin D and the lipid ratios and 
comparison of the vitamin with the lipid ratios and 
adiponectin as predictors of insulin resistance and 
insulin sensitivity.
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Therefore, the aims of the current study were to 
assess maternal serum values of vitamin D, adiponectin 
and the lipid ratios and comparison of their associations 
with insulin resistance and insulin sensitivity in GDM.
Material and methods
This case-control study was approved by the In-
stitutional Ethical Review Board of Lorestan University 
of Medical Sciences (LUMS.REC.1395.223). It has been 
reported that Iranian pregnant women are suffering 
from vitamin D deficiency with a prevalence of 42%, 
56% and 81% based on cutoff values of 10, 20 and 30 
ng/mL, respectively. Therefore, proper supplementation 
with vitamin D has been advised to prevent side effects 
of its deficiency during pregnancy [10].
According to the 75-g oral glucose tolerance test 
[11] to detect GDM, case (49 nulliparous newly diag-
nosed GDM before insulin or any drug treatment) and 
control (51 nulliparous normal pregnant women) sub-
jects were enrolled in the current study after assignment 
of informed consent. Blood samples were obtained at 
24–28 weeks of gestation. The current study was per-
formed in spring season. Treatment with insulin, using 
vitamin D supplements, preeclampsia, multiple gesta-
tion, type 1 or 2 diabetes mellitus, chronic hypertension, 
body mass index (BMI) > 30 kg/m2 and smoking were 
exclusion criteria of the current study [7].
Fasting maternal serum levels of glucose (FBG) and 
lipid profile including triglyceride (TG), total cholesterol 
(TC) and high-density lipoprotein cholesterol (HDL-C) 
were measured (Hitachi, Germany), while low-density 
lipoprotein cholesterol (LDL-C) and the lipid ratios 
including LDL-C/HDL-C, TG/HDL-C and TC/HDL-C were 
calculated [12, 13]. 25-hydroxy vitamin D3 [25(OH)D3] 
(IDS Ltd, Boldon, Tyne & Wear, UK), adiponectin (Bio-
Vendor Laboratory Medicine, Inc. Czech Republic) and 
insulin (Monobind Inc., USA) were measured by ELISA 
method (STAT FAX 3200, USA). Insulin resistance and 
insulin sensitivity were estimated using the homeostasis 
model assessment of insulin resistance (HOMA-IR) index 
[14] and the quantitative insulin sensitivity check index 
(QUICKI) [15] formulas, respectively. 
The Student t-test, Pearson’s correlation analysis, 
multiple linear regression analysis and binary logistic 
regression analysis were used to do statistical analyses 
using SPSS 19 software (SPSS Inc, Chicago, IL, USA). 
The collected data were expressed as mean ± standard 
error of mean (SEM) and were considered statistically 
significant at a P value less than 0.05.
Results
Comparison of demographic characteristics be-
tween control and case subjects are given in Table 1 
that shows no differences in age and BMI between 
two groups while case women had higher values of 
age. Biochemical characteristics of case and control 
groups were also summarized in Table 1. Values of 
fasting blood glucose (FBG), the lipid ratios including 
Table 1. Comparison of demographic characteristics and serum values of biochemichal variables between women with 
GDM and normal pregnant women 
Parameter Normal pregnant (n = 51) GDM (n = 49) P 
Age (years) 29.22 ± 0.64 31.61 ± 0.56 0.006
Gestational age (weeks) 25.96 ± 0.21 26.49 ± 0.21 0.076
BMI [kg/m2] 25.21 ± 0.34 25.38 ± 0.31 0.486
FBG [mg/dL] 78.49 ± 1.13 103.18 ± 2.27 < 0.001
TG [mg/dL] 214.45 ± 12.83 248.11 ± 16.51 0.163
TC [mg/dL] 239.33 ± 8.45 220.05 ± 8.75 0.066
HDL-C [mg/dL] 53.06 ± 2.25 32.15 ± 2.50 < 0.001
LDL-C [mg/dL] 143.38 ± 6.76 138.28 ± 8.61 0.398
TG/HDL-C ratio 4.86 ± 0.73 10.24 ± 1.21 < 0.001
TC/HDL-C ratio 5.02 ± 0.42 8.96 ± 0.78 < 0.001
LDL-C/HDL-C ratio 3.04 ± 0.29 5.92 ± 0.63 < 0.001
Insulin [µIU/mL] 7.91 ± 1.10 13.30 ± 1.93 0.016
HOMA-IR 1.51 ± 0.21 3.41 ± 0.50 < 0.001
QUICKI 0.31 ± 0.004 0.28 ± 0.005 < 0.001
Adiponectin [µg/mL] 6.45 ± 0.71 4.13 ± 0.33 < 0.001
25(OH)D3 [ng/mL] 17.62 ± 2.01 12.98 ± 1.10 0.035
Data are presented as mean ± SEM. BMI — body mass index; FBG — fasting blood glucose; TG — triglyceride; TC — total cholesterol; HDL-C — high-densi-
ty lipoprotein cholesterol; LDL-C — low-density lipoprotein cholesterol; HOMA-IR — the homeostasis model assessment of insulin resistance; QUICKI — the 
quantitative insulin sensitivity check index; 25(OH)D3 — 25-hydroxy vitamin D3
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LDL-C/HDL-C, TG/HDL-C and TC/HDL-C, and the HOMA-
-IR index were significantly increased while values 
of HDL-C, QUICKI, adiponectin and 25(OH)D3 were 
significantly decreased in the case women compared 
with normal control group. The differences of 25(OH)
D3 and adiponectin between the two groups were still 
statistically significant after the raw data were adjusted 
for the subjects’ age. 
In normal pregnant women, serum levels of 25(OH)
D3 correlated negatively with TC/HDL-C (r = –0.31, 
P = 0.029) (Fig. 1A) and HOMA-IR index (r = –0.39, 
P = 0.005) (Fig. 1B) and positively with QUICKI (r = 0.421, 
P = 0.002) (Fig. 1C). The HOMA-IR index correlated 
negatively with HDL-C (r = –0.58, P < 0.001) and posi-
tively with TG/HDL-C (r = 0.40, P = 0.004) and TC/HDL-C 
(r = 0.34, P = 0.015). The QUICKI showed a positive 
Figure 1. Correlations between serum levels of 25-hydroxy vitamin D3 (25(OH)D3) and values of (A) the total cholesterol/high-
-density lipoprotein cholesterol ratio (TC/HDL-C) (r = –0.31, P = 0.029) (B) the homeostasis model assessment of insulin resist-
ance (HOMA-IR) index (r = –0.39, P = 0.005) (C) the quantitative insulin sensitivity check index (QUICKI) (r = 0.421, P = 0.002) 
in 51 normal pregnant women and (D) correlation between fasting blood glucose and adiponectin (r = –0.39, P = 0.005) in 49 
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correlation with HDL-C (r = 0.58, P < 0.001) and nega-
tive correlations with TG/HDL-C (r = –0.37, P = 0.007) 
and TC/HDL-C (r = –0.31, P = 0.025). In GDM, fasting 
blood glucose correlated negatively with adiponectin 
(r = –0.39, P = 0.005) (Fig. 1D) and positively with TG/ 
/HDL-C (r = 0.36, P = 0.011). 
Whole study population (n = 100) correlations 
were also analyzed. Serum levels of 25(OH)D3 showed 
negative correlations with LDL-C/HDL-C (r = –0.23, 
P = 0.022) (Fig. 2A), TC/HDL-C (r = –0.24, P = 0.018) 
(Fig. 2B) and HOMA-IR (r = –0.35, P < 0.001) (Fig. 2C) 
and positive correlation with QUICKI (r = 0.37, P < 0.001) 
(Fig. 2D). The HOMA-IR index correlated negatively 
with HDL-C (r = –0.43, P < 0.001) and positively with 
LDL-C/HDL-C (r = 0.23, P = 0.022), TG/HDL-C (r = 0.41, 
P < 0.001), TC/HDL-C (r = 0.32, P = 0.001). The QUICKI 
showed a positive correlation with HDL-C (r = 0.44, 
P < 0.001) and negative correlations with TG/HDL-C 
Figure 2. Correlations between serum levels of 25-hydroxy vitamin D3 [25(OH)D3] and values of (A) the low-density lipoprotein 
cholesterol/high-density lipoprotein cholesterol ratio (LDL-C/HDL-C) (r = –0.23, P = 0.022) (B) the total cholesterol/high-density 
lipoprotein cholesterol ratio (TC/HDL-C) (r = –0.24, P = 0.018) (C) the homeostasis model assessment of insulin resistance (HOMA-
-IR) index (r = –0.35, P < 0.001) (D) the quantitative insulin sensitivity check index (QUICKI) (r = 0.37, P < 0.001) in the whole 
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(r = –0.34, P = 0.001) and TC/HDL-C (r = –0.25, 
P = 0.012). Fasting blood glucose showed negative 
correlation with adiponectin (r = –0.32, P = 0.001) 
and positive correlations with TG/HDL-C (r = 0.56, 
P < 0.001), LDL-C/HDL-C (r = 0.33, P = 0.001) and TC/ 
/HDL-C (r = 0.43, P < 0.001).
Multiple linear regression analysis showed that 
only values of 25(OH)D3 were independently associated 
with the HOMA-IR index (b = –0.25, P = 0.012) and 
the QUICKI (b = 0.27, P = 0.005). 
According to binary logistic regression analysis, the 
lipid ratios were positive risk factors for GDM develop-
ment while HDL-C, adiponectin and 25(OH)D3 were 
negative risk factors (Table 2). 
Discussion
In the current study we observed that values of 
25(OH)D3 decreased significantly in GDM compared 
with normal pregnancy and 25(OH)D3 significantly as-
sociated with insulin resistance, insulin sensitivity and 
atherogenic indexes.
Decreased maternal circulating levels of 25(OH)D3 
in GDM compared with normal pregnancy in the cur-
rent study were in line with previous studies including 
Maghbooli et al. [6], Ou et al. [7] and McManus et al. 
[16]. On the other hand, the current study was con-
tradicted to studies of El Lithy et al. [8], Mutlu et al. 
[9] and Pleskačová et al. [17], who have reported no 
significant differences in maternal circulating levels 
of 25(OH)D3 between GDM and normal pregnancy. A 
major limitation of some of these studies was that BMI 
was not similar between case and control group [6, 7, 
17], since it has been reported a negative correlation 
between serum levels of 25(OH)D3 and BMI. Therefore, 
it has been concluded that this negative correlation is 
due to this fact that most of vitamin D is stored in fat 
tissue [18].
Study of Takhshid et al. [14] showed that the 
HOMA-IR index is increased in GDM compared with 
normal pregnancy while no significant differences 
were observed in serum values of lipid profile, TG/ 
/HDL-C, adiponectin and the QUICKI between the two 
groups. On the other hand, current study confirmed 
decreased levels of both 25(OH)D3 and adiponectin in 
GDM that has been reported by McManus et al. [16]. 
The low levels of both 25(OH)D3 and adiponectin that 
was observed in the current study could be interpreted 
that vitamin D has inducing effects on adiponectin gene 
expression [18]. Anti-inflammatory, insulin sensitivity 
enhancing and atherosclerosis protecting effects of 
adiponectin have been reported previously [19]. Some 
antioxidant properties have been shown for vitamin D 
[20] and adiponectin [21, 22]. On the other hand, it 
has been reported that vitamin D has some beneficial 
effects against cardiovascular diseases which could 
be due to its positive effects on adiponectin’s gene 
expression [18]. Therefore, decreased levels of adi-
ponectin in women with GDM that was observed in 
the current study could be addressed that they had 
vitamin D deficiency.
No significant differences in serum values of lipid 
profile and the HOMA-IR index have been observed be-
tween GDM and normal pregnancy in a study that was 
conducted by Limura et al. [23]. They also observed that 
plasma lipid profile cannot be used to predict GDM. 
On the other hand, study of Wang et al. [24] showed 
that values of the TG/HDL-C ratio are higher in GDM 
than in normal pregnancy and the ratio is associated 
with the risks of GDM. Therefore, they concluded that 
for prediction of GDM risk the TG/HDL-C ratio can be 
used as a marker. The findings of the current study 
were in line with Wang et al. findings. Another study 
showed that higher values of TG in early pregnancy are 
associated with higher risk for developing GDM while 
higher values of HDL are associated with lower risk 
for the disease [25]. Study of Liang et al. [26] showed 
that circulating levels of TG and TC are increased in 
GDM compared with normal pregnancy and they are 
correlated directly with the HOMA-IR index. Liang et al. 
[26] concluded that maternal complications result from 
GDM could be improved partially by reducing insulin 
resistance and circulating lipids. In the current study, 
the HOMA-IR index showed a negative correlation with 
HDL-C and positive correlations with all the lipid ratios 
and insulin sensitivity was lower in GDM than in normal 
pregnancy that confirmed Liang et al. [26] study. In the 
current study, multiple linear regression analysis of the 
dependent variables including HOMA-IR and QUICKI 
with values of 25(OH)D3, adiponectin and the lipid ra-
tios was also performed. The regression model showed 
that only values of 25(OH)D3 were independently 
associated with both HOMA-IR and QUICKI. Previous 
Table 2. Binary logistic regression analysis of the effects 
of the variables on gestational diabetes mellitus 
Variables B OR 95% CI for OR P 
TG/HDL-C ratio 0.22 1.24 1.10–1.41 0.001
TC/HDL-C ratio 0.33 1.39 1.15–1.68 0.001
LDL-C/HDL-C ratio 0.36 1.43 1.16–1.78 0.001
HDL-C –0.074 0.93 0.90–0.96 < 0.001
Adiponectin –0.28 0.76 0.62–0.92 0.005
25(OH)D3 –0.78 0.46 0.21–0.99 0.046
CI — confidence interval; OR — odds ratio; other abbreviations are given 
in Table 1
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studies have been reported that maternal serum levels 
of 25(OH)D3 are correlated inversely with the HOMA-
-IR index [6, 7, 9] that was confirmed by the current 
study. We also observed a positive correlation between 
levels of 25(OH)D3 and QUICKI that did not agree with 
Maghbooli et al. [6] and El Lithy et al. [8] studies, who 
have not observed any significant correlation. 
It has been reported that transport of glucose is 
increased into insulin-dependent cells by stimulating 
expression of insulin receptors in the presence of vita-
min D that leads to increased insulin sensitivity [2, 27]. 
Formation of foam cells and uptake of cholesterol 
by macrophages have been reported that are inhibited 
in the presence of vitamin D. This property of vitamin 
D is considered as its antiatherogenic property [5]. On 
the other hand, indirect correlalation has been reported 
between serum level of 25(OH)D3 and metabolic syn-
drome biomarkers [28]. There are little findings about 
the association between the lipid ratios and 25(OH)D3 
in GDM. In the current study, maternal serum levels of 
25(OH)D3 showed inverse correlations with the lipid 
ratios that confirmed the antiatherogenic properties 
of vitamin D.
Conclusions
In summary, serum levels of 25(OH)D3 were de-
creased significantly in GDM compared with normal 
pregnancy and showed statistically significant correla-
tions with metabolic syndrome biomarkers. 25(OH)D3 
had more significant correlations with insulin resista-
nce and sensitivity indexes than the lipid ratios and 
adiponectin. 
Acknowledgments
This work was supported by Lorestan University 
of Medical Sciences. The authors should appreciate all 
patients who participated in the current study.
Conflict of interest
The authors declared that they have no conflict 
of interest.
REFERENCES 
1. Korkmazer E, Solak N. Correlation between inflammatory mark-
ers and insulin resistance in pregnancy. J Obstet Gynaecol. 2015; 
35(2): 142–145, doi: 10.3109/01443615.2014.948408, indexed 
in Pubmed: 25111421.
2. Zhang MX, Pan GT, Guo JF, et al. Vitamin D deficiency increases 
the risk of gestational diabetes mellitus: a meta-analysis of 
observational studies. Nutrients. 2015; 7(10): 8366–8375, doi: 
10.3390/nu7105398, indexed in Pubmed: 26437429.
3. Rutkowska J, Bandurska-Stankiewicz E, Wiatr-Bykowska D, et al. 
Vitamin D deficiency in women with gestational diabetes mellitus. 
Clin Diabetol. 2016; 5(2): 57–61, doi: 10.5603/dk.2016.0010.
4. Rizzo G, Garzon S, Fichera M, et al. Vitamin D and gestational 
diabetes mellitus: is there a link? Antioxidants (Basel). 2019; 8(11), 
doi: 10.3390/antiox8110511, indexed in Pubmed: 31731439.
5. Mozos I, Marginean O. Links between Vitamin D deficiency and 
cardiovascular diseases. Biomed Res Int. 2015; 2015: 109275, doi: 
10.1155/2015/109275, indexed in Pubmed: 26000280.
6. Maghbooli Z, Hossein-Nezhad A, Karimi F, et al. Correlation be-
tween vitamin D3 deficiency and insulin resistance in pregnancy. 
Diabetes Metab Res Rev. 2008; 24(1): 27–32, doi: 10.1002/
dmrr.737, indexed in Pubmed: 17607661.
7. Wang Ou, Nie M, Hu YY, et al. Association between vitamin D 
insufficiency and the risk for gestational diabetes mellitus in 
pregnant Chinese women. Biomed Environ Sci. 2012; 25(4): 
399–406, doi: 10.3967/0895-3988.2012.04.004, indexed in 
Pubmed: 23026519.
8. El Lithy A, Abdella RM, El-Faissal YM, et al. The relationship be-
tween low maternal serum vitamin D levels and glycemic control 
in gestational diabetes assessed by HbA1c levels: an observational 
cross-sectional study. BMC Pregnancy Childbirth. 2014; 14: 362, 
doi: 10.1186/1471-2393-14-362, indexed in Pubmed: 25308347.
9. Mutlu N, Esra H, Begum A, et al. Relation of maternal vitamin D 
status with gestational diabetes mellitus and perinatal outcome. 
Afr Health Sci. 2015; 15(2): 523–531, doi: 10.4314/ahs.v15i2.27, 
indexed in Pubmed: 26124799.
10. Badfar G, Shohani M, Mansouri A, et al. Vitamin D status in Ira-
nian pregnant women and newborns: a systematic review and 
meta-analysis study. Expert Rev Endocrinol Metab. 2017; 12(5): 
379–389, doi: 10.1080/17446651.2017.1365596, indexed in 
Pubmed: 30058894.
11. American Diabetes Association. Diagnosis and classification of 
diabetes mellitus. Diabetes Care. 2014; 37 Suppl 1: S81–S90, doi: 
10.2337/dc14-S081, indexed in Pubmed: 24357215.
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concen-
tration of low-density lipoprotein cholesterol in plasma, without 
use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6): 
499–502, indexed in Pubmed: 4337382.
13. Zhang L, Chen S, Deng A, et al. Association between lipid ratios 
and insulin resistance in a Chinese population. PLoS One. 2015; 
10(1): e0116110, doi: 10.1371/journal.pone.0116110, indexed 
in Pubmed: 25635876.
14. Takhshid MA, Haem Z, Aboualizadeh F. The association of circulat-
ing adiponectin and + 45 T/G polymorphism of adiponectin gene 
with gestational diabetes mellitus in Iranian population. J Diabetes 
Metab Disord. 2015; 14: 30, doi: 10.1186/s40200-015-0156-z, 
indexed in Pubmed: 25909078.
15. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitiv-
ity check index: a simple, accurate method for assessing insulin 
sensitivity in humans. J Clin Endocrinol Metab. 2000; 85(7): 
2402–2410, doi: 10.1210/jcem.85.7.6661, indexed in Pubmed: 
10902785.
16. McManus R, Summers K, de Vrijer B, et al. Maternal, umbilical 
arterial and umbilical venous 25-hydroxyvitamin D and adipocy-
tokine concentrations in pregnancies with and without gesta-
tional diabetes. Clin Endocrinol (Oxf). 2014; 80(5): 635–641, doi: 
10.1111/cen.12325, indexed in Pubmed: 24102192.
17. Pleskačová A, Bartáková V, Pácal L, et al. Vitamin D status in 
women with gestational diabetes mellitus during pregnancy 
and postpartum. Biomed Res Int. 2015; 2015: 260624, doi: 
10.1155/2015/260624, indexed in Pubmed: 26000285.
18. Kardas F, Kendirci M, Kurtoglu S. Cardiometabolic risk fac-
tors related to vitamin D and adiponectin in obese children 
and adolescents. Int J Endocrinol. 2013; 2013: 503270, doi: 
10.1155/2013/503270, indexed in Pubmed: 23983686.
19. Frühbeck G, Catalán V, Rodríguez A, et al. Involvement of the 
leptin-adiponectin axis in inflammation and oxidative stress in 
the metabolic syndrome. Sci Rep. 2017; 7(1): 6619, doi: 10.1038/
s41598-017-06997-0, indexed in Pubmed: 28747790.
Ali Khosrowbeygi, Hassan Ahmadvand, Vitamin D, adiponectin and lipid ratios in GDM
327
20. Kostoglou-Athanassiou I, Athanassiou P, Gkountouvas A, et 
al. Vitamin D and glycemic control in diabetes mellitus type 
2. Ther Adv Endocrinol Metab. 2013; 4(4): 122–128, doi: 
10.1177/2042018813501189, indexed in Pubmed: 23997931.
21. Khosrowbeygi A, Ahmadvand H. Leptin to adiponectin ratio in 
preeclampsia. Bangladesh Med Res Counc Bull. 2013; 39(1): 
18–21, doi: 10.3329/bmrcb.v39i1.15805, indexed in Pubmed: 
23923407.
22. Ren Y, Li Y, Yan J, et al. Adiponectin modulates oxidative stress-
induced mitophagy and protects C2C12 myoblasts against 
apoptosis. Sci Rep. 2017; 7(1): 3209, doi: 10.1038/s41598-017-
03319-2, indexed in Pubmed: 28600493.
23. Iimura Y, Matsuura M, Yao Z, et al. Lack of predictive power of 
plasma lipids or lipoproteins for gestational diabetes mellitus in 
Japanese women. J Diabetes Investig. 2015; 6(6): 640–646, doi: 
10.1111/jdi.12363, indexed in Pubmed: 26543537.
24. Wang D, Xu S, Chen H, et al. The associations between triglyc-
eride to high-density lipoprotein cholesterol ratios and the risks 
of gestational diabetes mellitus and large-for-gestational-age 
infant. Clin Endocrinol (Oxf). 2015; 83(4): 490–497, doi: 10.1111/
cen.12742, indexed in Pubmed: 25665068.
25. Li G, Kong L, Zhang Li, et al. Early pregnancy maternal lipid 
profiles and the risk of gestational diabetes mellitus stratified 
for body mass index. Reprod Sci. 2015; 22(6): 712–717, doi: 
10.1177/1933719114557896, indexed in Pubmed: 25394643.
26. Liang Zx, Wu Y, Zhu Xy, et al. Insulin resistance and lipid profile 
during an oral glucose tolerance test in women with and without 
gestational diabetes mellitus. J Obstet Gynaecol. 2016; 36(3): 
337–339, doi: 10.3109/01443615.2015.1060197, indexed in 
Pubmed: 26466813.
27. Hu L, Zhang Y, Wang X, et al. Maternal Vitamin D status and risk 
of gestational diabetes: a meta-analysis. Cell Physiol Biochem. 
2018; 45(1): 291–300, doi: 10.1159/000486810, indexed in 
Pubmed: 29402818.
28. Barchetta I, De Bernardinis M, Capoccia D, et al. Hypovitaminosis 
D is independently associated with metabolic syndrome in obese 
patients. PLoS One. 2013; 8(7): e68689, doi: 10.1371/journal.
pone.0068689, indexed in Pubmed: 23935881.
